TAGRISSO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 07 Jun 2023)
What this means for you
Registered since 10 Jan 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86827065
- Registration number
- 5117285
- Mark type
- Design + words
- Filed
- 20 Nov 2015
- Published for opposition
- 21 Jun 2016
- Registered
- 10 Jan 2017
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prior registrations
Prosecution history
- 19 Feb 2026 — TEAS SECTION 8 & 9 RECEIVED
- 10 Jan 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 07 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Jun 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Dec 2022 — TEAS SECTION 8 & 15 RECEIVED
- 29 Nov 2022 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 25 Oct 2022 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 24 Oct 2022 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 19 Aug 2022 — POST REGISTRATION ACTION MAILED - SEC. 7
- 16 Aug 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Mar 2022 — TEAS SECTION 7 REQUEST RECEIVED
- 10 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED